HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.

Abstract
Therapeutic antibodies targeting programmed cell death 1 (PD-1) activate tumor-specific immunity and have shown remarkable efficacy in the treatment of melanoma. Yet, little is known about tumor cell-intrinsic PD-1 pathway effects. Here, we show that murine and human melanomas contain PD-1-expressing cancer subpopulations and demonstrate that melanoma cell-intrinsic PD-1 promotes tumorigenesis, even in mice lacking adaptive immunity. PD-1 inhibition on melanoma cells by RNAi, blocking antibodies, or mutagenesis of melanoma-PD-1 signaling motifs suppresses tumor growth in immunocompetent, immunocompromised, and PD-1-deficient tumor graft recipient mice. Conversely, melanoma-specific PD-1 overexpression enhances tumorigenicity, as does engagement of melanoma-PD-1 by its ligand, PD-L1, whereas melanoma-PD-L1 inhibition or knockout of host-PD-L1 attenuate growth of PD-1-positive melanomas. Mechanistically, the melanoma-PD-1 receptor modulates downstream effectors of mTOR signaling. Our results identify melanoma cell-intrinsic functions of the PD-1:PD-L1 axis in tumor growth and suggest that blocking melanoma-PD-1 might contribute to the striking clinical efficacy of anti-PD-1 therapy.
AuthorsSonja Kleffel, Christian Posch, Steven R Barthel, Hansgeorg Mueller, Christoph Schlapbach, Emmanuella Guenova, Christopher P Elco, Nayoung Lee, Vikram R Juneja, Qian Zhan, Christine G Lian, Rahel Thomi, Wolfram Hoetzenecker, Antonio Cozzio, Reinhard Dummer, Martin C Mihm Jr, Keith T Flaherty, Markus H Frank, George F Murphy, Arlene H Sharpe, Thomas S Kupper, Tobias Schatton
JournalCell (Cell) Vol. 162 Issue 6 Pg. 1242-56 (Sep 10 2015) ISSN: 1097-4172 [Electronic] United States
PMID26359984 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • B7-H1 Antigen
  • PDCD1 protein, human
  • Pdcd1 protein, mouse
  • Programmed Cell Death 1 Receptor
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • B7-H1 Antigen (genetics)
  • Cell Line, Tumor
  • Cells, Cultured
  • Gene Knockdown Techniques
  • Heterografts
  • Humans
  • Melanoma (genetics)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Programmed Cell Death 1 Receptor (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: